Deal facts
- Buyer
- Novacyt Holdings UK Limited
- Target
- Southern Cross Diagnostics Pty Ltd
- Deal value
- Not disclosed
- Announced
- 2 March 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- Australia
- Consideration
- Not stated
Sources
Novacyt Holdings UK Limited has agreed to acquire Southern Cross Diagnostics Pty Ltd in a strategic acquisition within the molecular diagnostics sector. The transaction was announced and completed on 2 March 2026, with the target operating out of Australia. The deal value and specific consideration terms were not disclosed to the public at the time of the announcement.
This acquisition brings the Australian diagnostic business under the ownership of the UK-based parent company, expanding its presence in the Southern Hemisphere. The integration of Southern Cross Diagnostics into the Novacyt group marks a significant step for the buyer in the molecular diagnostics field. The transaction is now complete following the successful closing on the announced date.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Novacyt Holdings UK Limited to acquire Southern Cross Diagnostics Pty Ltd
{ "headline": "Completion of Acquisition", "issuer": "Novacyt S.A. (CDI) (NCYT)", "announcement_date": "2026-03-02T07:00:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n \n\n \n\n Novacyt S.A. \n\n (\"Novacyt\", the \"Company\" or the \"Group\") \n\n \n\n Completion of Acquisition \n\n \n\n Paris, France, and Manchester, UK - 2 March 2026 - Novacyt S.A.
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Hepion Pharmaceuticals, Inc. to acquire Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. has agreed to acquire Gravitas Life Sciences, LLC in a strategic acquisition. The transaction, valued at 4.25 million US dollars, was comple…
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gravitas Life Sciences, LLC
- Deal value
- USD 4,250,000
- Deal type
- strategic acquisition
BC PARTNERS to acquire ACS DOBFAR
BC PARTNERS has agreed to acquire ACS DOBFAR in a strategic acquisition within the healthcare sector. The transaction was announced on 8 October 2026. No specific financ…
- Buyer
- BC PARTNERS
- Target
- ACS DOBFAR
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
SRX Global Inc. to acquire CERo Therapeutics, Inc.
SRX Global Inc. has agreed to acquire CERo Therapeutics, Inc. in a strategic transaction within the healthcare sector. Both the buyer and the target are based in the Uni…
- Buyer
- SRX Global Inc.
- Target
- CERo Therapeutics, Inc.
- Deal value
- USD 1,000,000
- Deal type
- strategic acquisition
Repligen to acquire BioLife
Repligen has agreed to acquire BioLife in a strategic acquisition completed on 6 October 2026. Both companies are based in the United States and operate within the healt…
- Buyer
- Repligen
- Target
- BioLife
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Novacyt Holdings UK Limited
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive